238 related articles for article (PubMed ID: 26382091)
1. Systemic Mastocytosis: Clinical Update and Future Directions.
Tremblay D; Carreau N; Kremyanskaya M; Mascarenhas J
Clin Lymphoma Myeloma Leuk; 2015 Dec; 15(12):728-38. PubMed ID: 26382091
[TBL] [Abstract][Full Text] [Related]
2. Systemic mastocytosis in adults: 2019 update on diagnosis, risk stratification and management.
Pardanani A
Am J Hematol; 2019 Mar; 94(3):363-377. PubMed ID: 30536695
[TBL] [Abstract][Full Text] [Related]
3. Systemic mastocytosis in adults: 2012 Update on diagnosis, risk stratification, and management.
Pardanani A
Am J Hematol; 2012 Apr; 87(4):401-11. PubMed ID: 22410759
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological treatment options for mast cell activation disease.
Molderings GJ; Haenisch B; Brettner S; Homann J; Menzen M; Dumoulin FL; Panse J; Butterfield J; Afrin LB
Naunyn Schmiedebergs Arch Pharmacol; 2016 Jul; 389(7):671-94. PubMed ID: 27132234
[TBL] [Abstract][Full Text] [Related]
5. Systemic mastocytosis in adults: 2015 update on diagnosis, risk stratification, and management.
Pardanani A
Am J Hematol; 2015 Mar; 90(3):250-62. PubMed ID: 25688753
[TBL] [Abstract][Full Text] [Related]
6. Diagnosis and management of mastocytosis: an emerging challenge in applied hematology.
Valent P
Hematology Am Soc Hematol Educ Program; 2015; 2015():98-105. PubMed ID: 26637707
[TBL] [Abstract][Full Text] [Related]
7. Systemic mastocytosis in adults: 2013 update on diagnosis, risk stratification, and management.
Pardanani A
Am J Hematol; 2013 Jul; 88(7):612-24. PubMed ID: 23720340
[TBL] [Abstract][Full Text] [Related]
8. Relevant updates in systemic mastocytosis.
Coltoff A; Mascarenhas J
Leuk Res; 2019 Jun; 81():10-18. PubMed ID: 30978435
[TBL] [Abstract][Full Text] [Related]
9. Systemic mastocytosis in adults: 2017 update on diagnosis, risk stratification and management.
Pardanani A
Am J Hematol; 2016 Nov; 91(11):1146-1159. PubMed ID: 27762455
[TBL] [Abstract][Full Text] [Related]
10. Systemic mastocytosis in adults: 2011 update on diagnosis, risk stratification, and management.
Pardanani A
Am J Hematol; 2011 Apr; 86(4):362-71. PubMed ID: 21442641
[TBL] [Abstract][Full Text] [Related]
11. Mastocytosis: state of the art.
Horny HP; Sotlar K; Valent P
Pathobiology; 2007; 74(2):121-32. PubMed ID: 17587883
[TBL] [Abstract][Full Text] [Related]
12. [Therapeutically relevant mutations in the receptor tyrosine kinase KIT in mastocytosis].
Sotlar K
Verh Dtsch Ges Pathol; 2007; 91():169-76. PubMed ID: 18314612
[TBL] [Abstract][Full Text] [Related]
13. Current treatment options in patients with mastocytosis: status in 2015 and future perspectives.
Arock M; Akin C; Hermine O; Valent P
Eur J Haematol; 2015 Jun; 94(6):474-90. PubMed ID: 25753531
[TBL] [Abstract][Full Text] [Related]
14. Systemic mastocytosis.
Ozdemir D; Dagdelen S; Erbas T
Am J Med Sci; 2011 Nov; 342(5):409-15. PubMed ID: 21629042
[TBL] [Abstract][Full Text] [Related]
15. Systemic mastocytosis in adults: 2021 Update on diagnosis, risk stratification and management.
Pardanani A
Am J Hematol; 2021 Apr; 96(4):508-525. PubMed ID: 33524167
[TBL] [Abstract][Full Text] [Related]
16. Advanced systemic mastocytosis: from molecular and genetic progress to clinical practice.
Ustun C; Arock M; Kluin-Nelemans HC; Reiter A; Sperr WR; George T; Horny HP; Hartmann K; Sotlar K; Damaj G; Hermine O; Verstovsek S; Metcalfe DD; Gotlib J; Akin C; Valent P
Haematologica; 2016 Oct; 101(10):1133-1143. PubMed ID: 27694501
[TBL] [Abstract][Full Text] [Related]
17. New Insights into the Pathogenesis of Mastocytosis: Emerging Concepts in Diagnosis and Therapy.
Valent P; Akin C; Sperr WR; Horny HP; Arock M; Metcalfe DD; Galli SJ
Annu Rev Pathol; 2023 Jan; 18():361-386. PubMed ID: 36270293
[TBL] [Abstract][Full Text] [Related]
18. Systemic mastocytosis in adults: 2023 update on diagnosis, risk stratification and management.
Pardanani A
Am J Hematol; 2023 Jul; 98(7):1097-1116. PubMed ID: 37309222
[TBL] [Abstract][Full Text] [Related]
19. [Systemic mastocytosis--new therapeutic strategies].
Maniu CM; Ribi C; Spertini F
Rev Med Suisse; 2013 Jan; 9(368):17-21. PubMed ID: 23367698
[TBL] [Abstract][Full Text] [Related]
20. Mast cell proliferative disorders: current view on variants recognized by the World Health Organization.
Valent P; Akin C; Sperr WR; Horny HP; Metcalfe DD
Hematol Oncol Clin North Am; 2003 Oct; 17(5):1227-41. PubMed ID: 14560784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]